CM Management’s Cymabay Therapeutics CBAY Stock Holding History

CM Management’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-160,000	Closed	-$1M	–	75
2022 Q4	$1M	Buy	160,000 +60,000	+60%	+$228K	1.2%	27
2022 Q3	$350K	Sell	100,000 -110,000	-52%	-$395K	0.39%	62
2022 Q2	$620K	Buy	210,000 +60,000	+40%	+$143K	0.66%	48
2022 Q1	$467K	Hold	150,000	–	–	0.39%	64
2021 Q4	$507K	Hold	150,000	–	–	0.38%	73
2021 Q3	$548K	Hold	150,000	–	–	0.41%	71
2021 Q2	$654K	Hold	150,000	–	–	0.47%	67
2021 Q1	$681K	Buy	+150,000	New	+$807K	0.51%	68

Other funds holding CBAY

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return